Kaiyin Wu Selected Research

Inflammation (Inflammations)

1/2020	Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept.
10/2019	IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus Nephritis.
1/2016	Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
8/2015	The Relationship of the Severity and Category of Acute Rejection With Intimal Arteritis Defined in Banff Classification to Clinical Outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kaiyin Wu Research Topics

Disease

5	Fibrosis (Cirrhosis) 12/2018 - 06/2006
5	Urinary Tract Infections (Urinary Tract Infection) 12/2018 - 04/2016
4	Proteinuria 01/2021 - 12/2015
4	Inflammation (Inflammations) 01/2020 - 08/2015
4	Atrophy 12/2018 - 04/2016
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2019 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 10/2017
2	Body Weight (Weight, Body) 01/2018 - 01/2014
2	Neoplasms (Cancer) 10/2016 - 02/2015
1	Chronic Renal Insufficiency 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Lupus Nephritis 10/2019
1	Nephritis 01/2019
1	Infections 12/2018
1	Leukopenia 10/2017
1	Lung Neoplasms (Lung Cancer) 10/2016
1	Kidney Diseases (Kidney Disease) 04/2016
1	Arteritis 02/2016
1	Ischemia 01/2016
1	Reperfusion Injury 01/2016
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 12/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2015
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 06/2015
1	Heart Diseases (Heart Disease) 06/2015
1	Heart Failure 06/2015
1	Colonic Neoplasms (Colon Cancer) 02/2015
1	Hypertension (High Blood Pressure) 01/2014
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 12/2011

Drug/Important Bio-Agent (IBA)

3	MicroRNAs (MicroRNA)IBA 01/2018 - 04/2016
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 01/2018
2	CreatinineIBA 01/2021 - 08/2016
2	Epoxide HydrolasesIBA 01/2019 - 01/2016
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2019 - 01/2016
2	Messenger RNA (mRNA)IBA 12/2018 - 11/2016
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 04/2016
1	TRPC6 Cation ChannelIBA 01/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021
1	Abatacept (Orencia)FDA Link 01/2020
1	Calcineurin InhibitorsIBA 01/2020
1	Interleukin-2 (IL2)IBA 10/2019
1	Arachidonic Acid (Vitamin F)IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Complement System Proteins (Complement)IBA 12/2018
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	N 30IBA 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2017
1	Blood Proteins (Serum Proteins)IBA 11/2016
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2016
1	Metallothionein 3IBA 10/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2016
1	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 01/2016
1	AcidsIBA 01/2016
1	EicosanoidsIBA 01/2016
1	Urokinase Plasminogen Activator ReceptorsIBA 12/2015
1	AntibodiesIBA 08/2015
1	Antimicrobial PeptidesIBA 02/2015
1	CateninsIBA 02/2015
1	CathelicidinsIBA 02/2015
1	Neutralizing AntibodiesIBA 02/2015
1	capsazepineIBA 01/2014
1	Capsaicin (Zostrix)FDA Link 01/2014
1	Complement Factor B (Factor B)IBA 12/2011
1	AutoantibodiesIBA 12/2011
1	Valsartan (Vals)FDA Link 06/2006

Therapy/Procedure

4	Kidney Transplantation 01/2021 - 06/2015
3	Therapeutics 10/2019 - 12/2015
1	Drug Tapering 10/2017
1	Aftercare (After-Treatment) 08/2016
1	Plasma Exchange 12/2015
1	Combined Modality Therapy 12/2015
1	Denervation 01/2014
1	Nephrectomy 06/2006